share_log

藥明康德：翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

Hong Kong Stock Exchange ·  Apr 25 04:30
Summary by Moomoo AI
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月25日期間，進行了多次A股股份回購。根據公司提交的翌日披露報表，公司在上述期間內共回購了數百萬股A股，每次回購的股份數目及發生變動的日期均有詳細記錄。回購價格與市場價格相比，有時呈現折讓，有時則為溢價。該系列股份回購活動的最後一筆交易發生在2024年4月25日，當日公司回購了478,983股A股，總金額為人民幣20,046,254.27元。此外，報表中還確認了所有相關的法律和規則要求均已遵守，並且股份回購是根據上海證券交易所的適用規則進行的。
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月25日期間，進行了多次A股股份回購。根據公司提交的翌日披露報表，公司在上述期間內共回購了數百萬股A股，每次回購的股份數目及發生變動的日期均有詳細記錄。回購價格與市場價格相比，有時呈現折讓，有時則為溢價。該系列股份回購活動的最後一筆交易發生在2024年4月25日，當日公司回購了478,983股A股，總金額為人民幣20,046,254.27元。此外，報表中還確認了所有相關的法律和規則要求均已遵守，並且股份回購是根據上海證券交易所的適用規則進行的。
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. conducted multiple share repurchases of A shares from March 8 to April 25, 2024. According to the Company's Next Day Disclosure Report, the Company repurchased a total of millions of shares of Class A during the above period, with detailed records of the number of shares repurchased and the date of the change. The repurchase price is sometimes a discount compared to the market price, and sometimes it is a premium. The last transaction of the series of share repurchases took place on April 25, 2024, on which day the company repurchased 478,983 shares of A-shares for a total amount of RMB20,046,254.27. In addition, the report confirms that all relevant legal and regulatory requirements have been complied with and that the share buyback was conducted in accordance with the applicable rules of the Shanghai Stock Exchange.
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. conducted multiple share repurchases of A shares from March 8 to April 25, 2024. According to the Company's Next Day Disclosure Report, the Company repurchased a total of millions of shares of Class A during the above period, with detailed records of the number of shares repurchased and the date of the change. The repurchase price is sometimes a discount compared to the market price, and sometimes it is a premium. The last transaction of the series of share repurchases took place on April 25, 2024, on which day the company repurchased 478,983 shares of A-shares for a total amount of RMB20,046,254.27. In addition, the report confirms that all relevant legal and regulatory requirements have been complied with and that the share buyback was conducted in accordance with the applicable rules of the Shanghai Stock Exchange.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more